Sorafenib in non-small cell lung cancer.

Sorafenib in non-small cell lung cancer.

Item
http://www.wikidata.org/entity/Q38020917
Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasisNon-small-cell lung cancer: molecular targeted therapy and personalized medicine - drug resistance, mechanisms, and strategiesSynergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling.HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells.Synthesis and Evaluation of Novel Erlotinib-NSAID Conjugates as More Comprehensive Anticancer Agents.Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells.Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer.[Clinical significance of ROS1 rearrangements in non-small cell lung cancer].Apatinib for heavily treated patients with non-small cell lung cancer: Report of a case series and literature review
P2860

Sorafenib in non-small cell lung cancer.

Item
http://www.wikidata.org/entity/Q38020917
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Sorafenib in non-small cell lung cancer.
@en
type
label
Sorafenib in non-small cell lung cancer.
@en
prefLabel
Sorafenib in non-small cell lung cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Sorafenib in non-small cell lung cancer.
@en
P2093
P2860
P304
P31
P356
10.1517/13543784.2012.699039
P407
P433
P478
P577
P698